Spyre Therapeutics, Inc. ($SYRE)
Filing Information
| Accession Number | 0001636282-26-000107 |
|---|---|
| Form Type | 4 |
| Filing Date | Sep 4, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
15,000
Total Value
$1,309,410.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Sep 1, 2026 | Sale | 2,500 | $86.36 | $215,900.00 | 565,040 | Direct | โ | View Details | |
Director | Common Stock | โ | Sep 1, 2026 | Sale | 8,400 | $87.15 | $732,060.00 | 556,640 | Direct | โ | View Details | |
Director | Common Stock | โ | Sep 1, 2026 | Sale | 3,700 | $88.06 | $325,822.00 | 552,940 | Direct | โ | View Details | |
Director | Common Stock | โ | Sep 1, 2026 | Sale | 400 | $89.07 | $35,628.00 | 552,540 | Direct | โ | View Details |